EXOLENS Trademark
Trademark Overview
On Tuesday, February 11, 2025, a trademark application was filed for EXOLENS with the United States Patent and Trademark Office. The USPTO has given the EXOLENS trademark a serial number of 99037289. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Friday, May 22, 2026. This trademark is owned by Flagship Labs 103, Inc.. The EXOLENS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:
Pharmaceutical research and development; scientific and medical research and development in the field of computational biology,
bioinformatics, genomics, biotechnology, diagnostics, and pharmaceuticals; temporary use of online, non-downloadable software
for drug development, namely, software for cellular diagnostic and research systems and for cellular isolation and analysis;
temporary use of online, non-downloadable software in the nature of a drug discovery platform, namely, software for cellular
diagnostic and research systems and for cellular isolation and analysis; temporary use of online, non-downloadable software in
the nature of a diagnostic platform used to isolate, fractionate, and interrogate cells as diagnostics; technical scientific consultation
and product development for others in the field of biotechnology and the development of pharmaceuticals and therapeutics;
research and development ...
General Information
| Serial Number | 99037289 |
| Word Mark | EXOLENS |
| Filing Date | Tuesday, February 11, 2025 |
| Status | 686 - PUBLISHED FOR OPPOSITION |
| Status Date | Friday, May 22, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, November 11, 2025 |
Trademark Statements
| Goods and Services | Pharmaceutical research and development; scientific and medical research and development in the field of computational biology,
bioinformatics, genomics, biotechnology, diagnostics, and pharmaceuticals; temporary use of online, non-downloadable software
for drug development, namely, software for cellular diagnostic and research systems and for cellular isolation and analysis;
temporary use of online, non-downloadable software in the nature of a drug discovery platform, namely, software for cellular
diagnostic and research systems and for cellular isolation and analysis; temporary use of online, non-downloadable software in
the nature of a diagnostic platform used to isolate, fractionate, and interrogate cells as diagnostics; technical scientific consultation
and product development for others in the field of biotechnology and the development of pharmaceuticals and therapeutics;
research and development in the field of computational biology, bioinformatics, genomics, biotechnology, diagnostics, and
pharmaceuticals; platform as a service (PAAS) featuring computer software platforms for research and development in the field of
computational biology, bioinformatics, genomics, biotechnology, and pharmaceuticals; platform as a service (PAAS) featuring
computer software platforms for cellular diagnostic and research services; platform as a service (PAAS) featuring computer
software platforms for cellular isolation and analysis; platform as a service (PAAS) featuring computer software platforms to
isolate, fractionate, and interrogate cells as diagnostics; all of the foregoing excluding optics and electro-optics and related
services |
Classification Information
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, February 11, 2025 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Flagship Labs 103, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Cambridge, MA 02142
US |
| Party Name | Flagship Labs 103, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Cambridge, MA 02142
US |
Trademark Events
| Event Date | Event Description |
| Tuesday, February 11, 2025 | NEW APPLICATION ENTERED |
| Tuesday, February 11, 2025 | APPLICATION FILING RECEIPT MAILED |
| Thursday, July 10, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Sunday, July 20, 2025 | ASSIGNED TO EXAMINER |
| Monday, July 21, 2025 | NON-FINAL ACTION WRITTEN |
| Monday, July 21, 2025 | NON-FINAL ACTION E-MAILED |
| Monday, July 21, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, October 6, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, October 6, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, October 6, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, October 10, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, November 5, 2025 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, November 11, 2025 | PUBLISHED FOR OPPOSITION |
| Tuesday, November 11, 2025 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Thursday, December 11, 2025 | EXTENSION OF TIME TO OPPOSE RECEIVED |
| Monday, January 26, 2026 | TEAS POST PUBLICATION AMENDMENT RECEIVED |
| Monday, March 23, 2026 | ASSIGNED TO PETITION STAFF |
| Thursday, March 26, 2026 | POST PUBLICATION AMENDMENT - ENTERED |
| Thursday, May 21, 2026 | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED |
